Mary Elizabeth Cunnane, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neck Dissection | 2 | 2016 | 201 | 0.590 |
Why?
|
| Neuroma, Acoustic | 3 | 2017 | 459 | 0.500 |
Why?
|
| Thyroid Neoplasms | 7 | 2023 | 2332 | 0.460 |
Why?
|
| Thyroid Gland | 3 | 2016 | 1168 | 0.460 |
Why?
|
| Thyroidectomy | 4 | 2023 | 902 | 0.440 |
Why?
|
| Ethmoid Sinus | 2 | 2009 | 57 | 0.400 |
Why?
|
| Orbit | 5 | 2020 | 446 | 0.400 |
Why?
|
| Endoscopy | 7 | 2017 | 1838 | 0.370 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2017 | 781 | 0.340 |
Why?
|
| Ethmoid Bone | 1 | 2009 | 35 | 0.320 |
Why?
|
| Tinnitus | 1 | 2011 | 194 | 0.320 |
Why?
|
| Tongue Neoplasms | 2 | 2018 | 183 | 0.270 |
Why?
|
| Cochlea | 2 | 2016 | 844 | 0.260 |
Why?
|
| Oculomotor Muscles | 2 | 2020 | 407 | 0.260 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3486 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2019 | 20509 | 0.250 |
Why?
|
| Sinusitis | 3 | 2014 | 990 | 0.240 |
Why?
|
| Carcinoma, Papillary | 3 | 2023 | 785 | 0.230 |
Why?
|
| Otologic Surgical Procedures | 2 | 2016 | 149 | 0.220 |
Why?
|
| Temporal Bone | 3 | 2017 | 683 | 0.220 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 11152 | 0.210 |
Why?
|
| Orbital Diseases | 2 | 2016 | 178 | 0.210 |
Why?
|
| Ear, Middle | 2 | 2014 | 338 | 0.190 |
Why?
|
| Audiometry | 3 | 2017 | 253 | 0.160 |
Why?
|
| Ophthalmoplegia | 1 | 2019 | 168 | 0.160 |
Why?
|
| Graves Ophthalmopathy | 1 | 2020 | 133 | 0.150 |
Why?
|
| Auditory Brain Stem Implantation | 1 | 2017 | 14 | 0.150 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2017 | 31 | 0.150 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2017 | 53 | 0.150 |
Why?
|
| Ultrasonography | 5 | 2018 | 5961 | 0.150 |
Why?
|
| Glossectomy | 1 | 2017 | 60 | 0.150 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2017 | 115 | 0.150 |
Why?
|
| Round Window, Ear | 1 | 2016 | 47 | 0.140 |
Why?
|
| Mouth Neoplasms | 2 | 2012 | 593 | 0.140 |
Why?
|
| Mucorales | 1 | 2016 | 35 | 0.130 |
Why?
|
| Ear, Inner | 2 | 2017 | 424 | 0.130 |
Why?
|
| Endoscopes | 1 | 2016 | 168 | 0.130 |
Why?
|
| Acrocephalosyndactylia | 1 | 2016 | 91 | 0.130 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 193 | 0.130 |
Why?
|
| Eye Infections, Fungal | 1 | 2016 | 100 | 0.120 |
Why?
|
| Mucormycosis | 1 | 2016 | 103 | 0.120 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2014 | 17 | 0.120 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2014 | 13 | 0.120 |
Why?
|
| Orbital Neoplasms | 1 | 2017 | 221 | 0.120 |
Why?
|
| Neck | 2 | 2016 | 731 | 0.120 |
Why?
|
| Orbital Fractures | 1 | 2015 | 109 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 2 | 2010 | 875 | 0.120 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2013 | 50 | 0.110 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2015 | 121 | 0.110 |
Why?
|
| Nasal Septum | 1 | 2014 | 130 | 0.110 |
Why?
|
| Maxillary Sinus | 1 | 2014 | 180 | 0.110 |
Why?
|
| Auditory Perception | 1 | 2017 | 580 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2019 | 817 | 0.110 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2014 | 166 | 0.100 |
Why?
|
| Otitis Media with Effusion | 1 | 2013 | 114 | 0.100 |
Why?
|
| Carcinoma, Lobular | 1 | 2017 | 489 | 0.100 |
Why?
|
| Paranasal Sinuses | 2 | 2012 | 265 | 0.100 |
Why?
|
| Brain Stem | 1 | 2017 | 857 | 0.100 |
Why?
|
| Intraoperative Period | 2 | 2017 | 516 | 0.100 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2012 | 95 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2013 | 2256 | 0.100 |
Why?
|
| Laryngectomy | 1 | 2014 | 243 | 0.100 |
Why?
|
| Infratentorial Neoplasms | 1 | 2012 | 98 | 0.100 |
Why?
|
| Thyroglossal Cyst | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cochlear Implantation | 1 | 2016 | 315 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2015 | 720 | 0.100 |
Why?
|
| Nasal Polyps | 2 | 2014 | 395 | 0.100 |
Why?
|
| Ear Canal | 2 | 2016 | 146 | 0.090 |
Why?
|
| Mouth Floor | 1 | 2011 | 38 | 0.090 |
Why?
|
| Tongue Diseases | 1 | 2011 | 68 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 857 | 0.090 |
Why?
|
| Paraproteinemias | 1 | 2013 | 246 | 0.090 |
Why?
|
| Dermoid Cyst | 1 | 2011 | 92 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2019 | 36290 | 0.090 |
Why?
|
| Angiofibroma | 1 | 2010 | 55 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2014 | 948 | 0.080 |
Why?
|
| Ethmoid Sinusitis | 1 | 2008 | 25 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 2943 | 0.080 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2008 | 59 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 869 | 0.080 |
Why?
|
| Physical Examination | 1 | 2014 | 1244 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2526 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2145 | 0.080 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 785 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 58995 | 0.070 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2008 | 86 | 0.070 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2010 | 286 | 0.070 |
Why?
|
| Vision Disorders | 2 | 2018 | 1084 | 0.070 |
Why?
|
| Rhinitis | 1 | 2014 | 746 | 0.070 |
Why?
|
| Vestibular Aqueduct | 1 | 2007 | 73 | 0.070 |
Why?
|
| Optic Neuritis | 1 | 2008 | 174 | 0.070 |
Why?
|
| Aged | 15 | 2017 | 169152 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 1008 | 0.070 |
Why?
|
| Radiography | 2 | 2011 | 6965 | 0.060 |
Why?
|
| Thyroid Nodule | 1 | 2013 | 760 | 0.060 |
Why?
|
| Ear Neoplasms | 1 | 2006 | 118 | 0.060 |
Why?
|
| Cytological Techniques | 1 | 2007 | 218 | 0.060 |
Why?
|
| Disease Management | 1 | 2016 | 2514 | 0.060 |
Why?
|
| Male | 25 | 2017 | 359744 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2159 | 0.060 |
Why?
|
| Diagnosis, Differential | 7 | 2018 | 12965 | 0.060 |
Why?
|
| Humans | 38 | 2023 | 760621 | 0.060 |
Why?
|
| Middle Aged | 18 | 2017 | 220352 | 0.060 |
Why?
|
| Adult | 19 | 2018 | 219994 | 0.060 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2008 | 471 | 0.060 |
Why?
|
| Aspirin | 1 | 2016 | 3364 | 0.060 |
Why?
|
| Fibrosis | 1 | 2011 | 2042 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2023 | 80372 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 8950 | 0.050 |
Why?
|
| Female | 22 | 2019 | 391270 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 4024 | 0.050 |
Why?
|
| Biopsy | 4 | 2019 | 6771 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2009 | 1479 | 0.050 |
Why?
|
| Patient Selection | 2 | 2017 | 4283 | 0.050 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2002 | 101 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2007 | 1274 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2002 | 152 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4541 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 318 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2017 | 1818 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 4048 | 0.050 |
Why?
|
| Nasal Obstruction | 2 | 2014 | 159 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1215 | 0.040 |
Why?
|
| Contrast Media | 4 | 2013 | 5305 | 0.040 |
Why?
|
| Barium Sulfate | 1 | 2000 | 180 | 0.040 |
Why?
|
| Enema | 1 | 2000 | 141 | 0.040 |
Why?
|
| Thoracic Neoplasms | 1 | 2002 | 266 | 0.040 |
Why?
|
| Neurofibromatosis 2 | 2 | 2017 | 385 | 0.040 |
Why?
|
| Young Adult | 5 | 2017 | 58741 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 1121 | 0.040 |
Why?
|
| Glaucoma | 1 | 2008 | 1182 | 0.040 |
Why?
|
| Thorax | 1 | 2002 | 553 | 0.040 |
Why?
|
| Biopsy, Needle | 3 | 2011 | 1630 | 0.040 |
Why?
|
| Microsurgery | 2 | 2016 | 796 | 0.040 |
Why?
|
| Reoperation | 2 | 2023 | 4291 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2014 | 14660 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1690 | 0.040 |
Why?
|
| Spinal Puncture | 1 | 2018 | 281 | 0.030 |
Why?
|
| Mouth | 1 | 2018 | 380 | 0.030 |
Why?
|
| Prognosis | 3 | 2014 | 29658 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2017 | 244 | 0.030 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2015 | 87 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 384 | 0.030 |
Why?
|
| History of Medicine | 1 | 1975 | 42 | 0.030 |
Why?
|
| Foundations | 1 | 1975 | 97 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2023 | 9287 | 0.030 |
Why?
|
| Training Support | 1 | 1975 | 108 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4902 | 0.030 |
Why?
|
| Skull Fractures | 1 | 2015 | 202 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 492 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2002 | 2007 | 0.030 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2016 | 353 | 0.030 |
Why?
|
| Biology | 1 | 1975 | 290 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 796 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2002 | 2634 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 1345 | 0.030 |
Why?
|
| Adolescent | 3 | 2016 | 87810 | 0.020 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 112 | 0.020 |
Why?
|
| Deafness | 1 | 2016 | 457 | 0.020 |
Why?
|
| Calcitonin | 1 | 2013 | 330 | 0.020 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 173 | 0.020 |
Why?
|
| Cochlear Implants | 1 | 2016 | 338 | 0.020 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 319 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2016 | 749 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 568 | 0.020 |
Why?
|
| Paralysis | 1 | 2012 | 251 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2006 | 3484 | 0.020 |
Why?
|
| Morbidity | 1 | 2016 | 1765 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 65017 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2016 | 464 | 0.020 |
Why?
|
| Carcinoma | 1 | 2002 | 2331 | 0.020 |
Why?
|
| Headache | 1 | 2018 | 1249 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 814 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 377 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 666 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 21025 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2013 | 832 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2016 | 780 | 0.020 |
Why?
|
| Enophthalmos | 1 | 2008 | 34 | 0.020 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2013 | 346 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2008 | 138 | 0.020 |
Why?
|
| Career Choice | 1 | 1975 | 754 | 0.020 |
Why?
|
| Tongue | 1 | 2011 | 404 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 1110 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1832 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15289 | 0.020 |
Why?
|
| Iopamidol | 1 | 2007 | 186 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5201 | 0.020 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2007 | 60 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39261 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2007 | 153 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1363 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15697 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 1975 | 1116 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2011 | 706 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2017 | 42063 | 0.020 |
Why?
|
| Hearing Disorders | 1 | 2006 | 126 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26951 | 0.020 |
Why?
|
| Mycoses | 1 | 2008 | 387 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 959 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2008 | 386 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9276 | 0.020 |
Why?
|
| Stroke | 1 | 2007 | 9962 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1502 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 8986 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 1975 | 0.010 |
Why?
|
| Piperidines | 1 | 2013 | 1650 | 0.010 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2007 | 325 | 0.010 |
Why?
|
| Child | 2 | 2009 | 79806 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11071 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3618 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2002 | 530 | 0.010 |
Why?
|
| Decision Making | 1 | 1975 | 3925 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2016 | 54303 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15840 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2002 | 956 | 0.010 |
Why?
|
| ROC Curve | 1 | 2007 | 3568 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 599 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25942 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14372 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18957 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2006 | 1688 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2758 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 5066 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 5877 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6465 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7269 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2475 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 36060 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13502 | 0.010 |
Why?
|
| Software | 1 | 2008 | 4419 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 5039 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5508 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20080 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 24123 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 81208 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7850 | 0.000 |
Why?
|
| Animals | 1 | 2014 | 167963 | 0.000 |
Why?
|
| United States | 1 | 1975 | 72461 | 0.000 |
Why?
|